Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mah

Showing results (161-170 of 264) with videos related to

Pageof 27
Sort By:
Domestic Animal Endocrinology|September 29, 2009
Evidence for a potential role of neuropeptide Y in ovine corpus luteum functionC S Keator, E E Custer, T A Hoagland, et al.
Clinical Genetics|September 30, 2016
Expansion of the GLE1-associated arthrogryposis multiplex congenita clinical spectrumC Smith, J S Parboosingh, K M Boycott, et al.
Pediatric Diabetes|September 21, 2022
Corneal nerve and nerve conduction abnormalities in children with type 1 diabetesDanièle Pacaud, Kenneth G Romanchuk, Heidi Virtanen, et al.
Cardiology in the Young|December 13, 2016
Cardiac manifestations of congenital LMNA-related muscular dystrophy in children: three case reports and recommendations for careFelice Heller, Ivana Dabaj, Jean K Mah, et al.
Journal of Medical Economics|December 15, 2021
Epidemiology, healthcare resource utilization and healthcare costs for spinal muscular atrophy in Alberta, CanadaGuanmin Chen, Behnam Sharif, Brittany Gerber, et al.
Orphanet Journal of Rare Diseases|May 27, 2026
Implementation of a neuromuscular clinical trial network: a rare disease model for enhancing clinical trial readiness, capacity, and access in CanadaKerri Lynn Schellenberg, Homira Osman, Maria Masnata, et al.
Neurology|November 2, 2014
Functional-structural correlations in the afferent visual pathway in pediatric demyelinationE Ann Yeh, Ruth Ann Marrie, Y Arun Reginald, et al.
Muscle & Nerve|July 28, 2016
Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trialCraig Campbell, Hugh J McMillan, Jean K Mah, et al.
Molecular Biology of the Cell|October 6, 2006
The WD repeat-containing protein IFTA-1 is required for retrograde intraflagellar transportOliver E Blacque, Chunmei Li, Peter N Inglis, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 5, 2024
A Study on the Incidence and Prevalence of 5q Spinal Muscular Atrophy in Canada Using Multiple Data SourcesTiffany R Price, Victoria Hodgkinson, Grace Westbury, et al.
Pageof 27

Showing results (161-170 of 264) with videos related to

Sort By:
Pageof 27
Domestic Animal Endocrinology|September 29, 2009
Evidence for a potential role of neuropeptide Y in ovine corpus luteum functionC S Keator, E E Custer, T A Hoagland, et al.
Clinical Genetics|September 30, 2016
Expansion of the GLE1-associated arthrogryposis multiplex congenita clinical spectrumC Smith, J S Parboosingh, K M Boycott, et al.
Pediatric Diabetes|September 21, 2022
Corneal nerve and nerve conduction abnormalities in children with type 1 diabetesDanièle Pacaud, Kenneth G Romanchuk, Heidi Virtanen, et al.
Cardiology in the Young|December 13, 2016
Cardiac manifestations of congenital LMNA-related muscular dystrophy in children: three case reports and recommendations for careFelice Heller, Ivana Dabaj, Jean K Mah, et al.
Journal of Medical Economics|December 15, 2021
Epidemiology, healthcare resource utilization and healthcare costs for spinal muscular atrophy in Alberta, CanadaGuanmin Chen, Behnam Sharif, Brittany Gerber, et al.
Orphanet Journal of Rare Diseases|May 27, 2026
Implementation of a neuromuscular clinical trial network: a rare disease model for enhancing clinical trial readiness, capacity, and access in CanadaKerri Lynn Schellenberg, Homira Osman, Maria Masnata, et al.
Neurology|November 2, 2014
Functional-structural correlations in the afferent visual pathway in pediatric demyelinationE Ann Yeh, Ruth Ann Marrie, Y Arun Reginald, et al.
Muscle & Nerve|July 28, 2016
Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trialCraig Campbell, Hugh J McMillan, Jean K Mah, et al.
Molecular Biology of the Cell|October 6, 2006
The WD repeat-containing protein IFTA-1 is required for retrograde intraflagellar transportOliver E Blacque, Chunmei Li, Peter N Inglis, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 5, 2024
A Study on the Incidence and Prevalence of 5q Spinal Muscular Atrophy in Canada Using Multiple Data SourcesTiffany R Price, Victoria Hodgkinson, Grace Westbury, et al.
Pageof 27